- (PLX AI) - BioNTech Q2 net income EUR 1,672 million vs. estimate EUR 1,900 million.
- • Q2 revenue EUR 3,196.5 million vs. estimate EUR 3,884 million
- • Q2 EPS EUR 6.45
- • CFO says well on track to achieve our previous financial guidance for the ongoing financial year
- • Says expect an uptake in demand in our key markets in the fourth quarter of 2022, subject to regulatory approval of variant-adapted COVID-19 vaccine candidates
© 2022 PLX AI